144 related articles for article (PubMed ID: 35087743)
1. Potential Defects and Improvements of Equivalent Uniform Dose Prediction Model Based on the Analysis of Radiation-Induced Brain Injury.
Du QH; Li J; Gan YX; Zhu HJ; Yue HY; Li XD; Ou X; Zhong QL; Luo DJ; Xie YT; Liang QF; Wang RS; Liu WQ
Front Oncol; 2021; 11():743941. PubMed ID: 35087743
[TBL] [Abstract][Full Text] [Related]
2. Half-Brain Delineation for Prediction of Radiation-Induced Temporal Lobe Injury in Nasopharyngeal Carcinoma Receiving Intensity-Modulated Radiotherapy.
Du QH; Gan YX; Wang RS; Liu WQ; Li J; Liang FF; Li XD; Zhu HJ; Ou X; Zhong QL; Luo DJ; Zhu ZP; Zhu SY
Front Oncol; 2021; 11():599942. PubMed ID: 33868994
[TBL] [Abstract][Full Text] [Related]
3. Predicting radiation pneumonitis in lung cancer: a EUD-based machine learning approach for volumetric modulated arc therapy patients.
Ye F; Xu L; Ren Y; Xia B; Chen X; Ma S; Deng Q; Li X
Front Oncol; 2024; 14():1343170. PubMed ID: 38357195
[TBL] [Abstract][Full Text] [Related]
4. The benefit of using bladder sub-volume equivalent uniform dose constraints in prostate intensity-modulated radiotherapy planning.
Zhu J; Simon A; Haigron P; Lafond C; Acosta O; Shu H; Castelli J; Li B; De Crevoisier R
Onco Targets Ther; 2016; 9():7537-7544. PubMed ID: 28003767
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric advantages of IMRT simultaneous integrated boost for high-risk prostate cancer.
Li XA; Wang JZ; Jursinic PA; Lawton CA; Wang D
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1251-7. PubMed ID: 15752907
[TBL] [Abstract][Full Text] [Related]
6. Equivalent uniform dose, D(90), and V(100) correlation with biochemical control after low-dose-rate prostate brachytherapy for clinically low-risk prostate cancer.
Miles EF; Nelson JW; Alkaissi AK; Das S; Clough RW; Anscher MS; Oleson JR
Brachytherapy; 2008; 7(2):206-11. PubMed ID: 18359669
[TBL] [Abstract][Full Text] [Related]
7. Accounting for fractionation and heterogeneous dose distributions in the modelling of osteoradionecrosis in oropharyngeal carcinoma treatment.
Verduijn GM; Sijtsema ND; van Norden Y; Heemsbergen WD; Mast H; Sewnaik A; Chin D; Baker S; Capala ME; van der Lugt A; van Meerten E; Hoogeman MS; Petit SF
Radiother Oncol; 2023 Nov; 188():109889. PubMed ID: 37659662
[TBL] [Abstract][Full Text] [Related]
8. Analysis of biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer using dose-distribution variables and tumor control probability models.
Levegrün S; Jackson A; Zelefsky MJ; Venkatraman ES; Skwarchuk MW; Schlegel W; Fuks Z; Leibel SA; Ling CC
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(5):1245-60. PubMed ID: 10889378
[TBL] [Abstract][Full Text] [Related]
9. The effect of breathing and set-up errors on the cumulative dose to a lung tumor.
Engelsman M; Damen EM; De Jaeger K; van Ingen KM; Mijnheer BJ
Radiother Oncol; 2001 Jul; 60(1):95-105. PubMed ID: 11410310
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity of treatment plan optimisation for prostate cancer using the equivalent uniform dose (EUD) with respect to the rectal wall volume parameter.
Schwarz M; Lebesque JV; Mijnheer BJ; Damen EM
Radiother Oncol; 2004 Nov; 73(2):209-18. PubMed ID: 15542168
[TBL] [Abstract][Full Text] [Related]
11. Clinical comparative study of dose-volume and equivalent uniform dose based predictions in post radiotherapy acute complications.
Boulé TP; Gallardo Fuentes MI; Roselló JV; Arrans Lara R; Torrecilla JL; Plaza AL
Acta Oncol; 2009; 48(7):1044-53. PubMed ID: 19575313
[TBL] [Abstract][Full Text] [Related]
12. Potential implications of the bystander effect on TCP and EUD when considering target volume dose heterogeneity.
Balderson MJ; Kirkby C
Int J Radiat Biol; 2015 Jan; 91(1):54-61. PubMed ID: 25004946
[TBL] [Abstract][Full Text] [Related]
13. Field size reduction enables iso-NTCP escalation of tumor control probability for irradiation of lung tumors.
Engelsman M; Remeijer P; van Herk M; Lebesque JV; Mijnheer BJ; Damen EM
Int J Radiat Oncol Biol Phys; 2001 Dec; 51(5):1290-8. PubMed ID: 11728689
[TBL] [Abstract][Full Text] [Related]
14. Comparison of predictive performance for toxicity by accumulative dose of DVH parameter addition and DIR addition for cervical cancer patients.
Miyasaka Y; Kadoya N; Umezawa R; Takayama Y; Ito K; Yamamoto T; Tanaka S; Dobashi S; Takeda K; Nemoto K; Iwai T; Jingu K
J Radiat Res; 2021 Jan; 62(1):155-162. PubMed ID: 33231258
[TBL] [Abstract][Full Text] [Related]
15. Incidence of late rectal bleeding in high-dose conformal radiotherapy of prostate cancer using equivalent uniform dose-based and dose-volume-based normal tissue complication probability models.
Söhn M; Yan D; Liang J; Meldolesi E; Vargas C; Alber M
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1066-73. PubMed ID: 17258870
[TBL] [Abstract][Full Text] [Related]
16. Prescription dose evaluation for APBI with noninvasive image-guided breast brachytherapy using equivalent uniform dose.
Leonard KL; Rivard MJ; Wazer DE; Hiatt JR; Sioshansi S; DiPetrillo TA; Hepel JT
Brachytherapy; 2015; 14(4):496-501. PubMed ID: 25900392
[TBL] [Abstract][Full Text] [Related]
17. A role for biological optimization within the current treatment planning paradigm.
Das S
Med Phys; 2009 Oct; 36(10):4672-82. PubMed ID: 19928099
[TBL] [Abstract][Full Text] [Related]
18. Fitting late rectal bleeding data using different NTCP models: results from an Italian multi-centric study (AIROPROS0101).
Rancati T; Fiorino C; Gagliardi G; Cattaneo GM; Sanguineti G; Borca VC; Cozzarini C; Fellin G; Foppiano F; Girelli G; Menegotti L; Piazzolla A; Vavassori V; Valdagni R
Radiother Oncol; 2004 Oct; 73(1):21-32. PubMed ID: 15465142
[TBL] [Abstract][Full Text] [Related]
19. Analysis of equivalent uniform dose (EUD) and conventional radiation treatment parameters after primary and re-irradiation of malignant glioma.
Niyazi M; Karin I; Söhn M; Nachbichler SB; Lang P; Belka C; Ganswindt U
Radiat Oncol; 2013 Dec; 8():287. PubMed ID: 24330746
[TBL] [Abstract][Full Text] [Related]
20. The theoretical benefit of beam fringe compensation and field size reduction for iso-normal tissue complication probability dose escalation in radiotherapy of lung cancer.
Engelsman M; Remeijer P; van Herk M; Mijnheer B; Damen E
Med Phys; 2003 Jun; 30(6):1086-95. PubMed ID: 12852532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
